Valuation Kobayashi Pharmaceutical Co., Ltd.

Stocks

4967

JP3301100008

Personal Products

Market Closed - 07:30:00 26/08/2026 BST 5-day change 1st Jan Change
5,691.00 JPY +0.19% Intraday chart for Kobayashi Pharmaceutical Co., Ltd. +2.67% +4.85%

Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 704,427 650,295 503,841 463,131 403,511 423,061 - -
Change - -7.68% -22.52% -8.08% -12.87% 4.85% - -
Enterprise Value (EV) 1 596,011 546,554 424,992 398,232 333,575 365,200 353,262 347,390
Change - -8.3% -22.24% -6.3% -16.24% 9.48% -3.27% -1.66%
P/E 35.8x 34.8x 25.3x 46x 110x 41.6x 31.2x 25.2x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 2.01x 1.96x 1.89x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 0.9x 1.1x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 2.45x 2.35x 2.27x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2.12x 1.96x 1.86x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 16.5x 13.1x 11.1x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 27.8x 20.2x 16.2x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 25.1x 23.1x 20.2x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 3.98% 4.33% 4.96%
Dividend per Share 2 83 90 101 102 104 106 109.5 114.3
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.86% 1.92% 2.01%
EPS 2 252.4 259.6 268.2 135.4 49.19 137 182.5 225.4
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 77.4% 60% 50.7%
Net sales 1 155,252 166,258 173,455 165,600 165,742 172,560 179,820 186,639
EBITDA 1 30,900 32,027 31,837 32,800 23,600 22,180 27,030 31,262
EBIT 1 26,065 26,669 25,780 24,860 14,923 13,125 17,494 21,464
Net income 1 19,715 20,022 20,338 10,067 3,656 10,255 13,674 16,493
Net Debt 1 -108,416 -103,741 -78,849 -64,899 -69,936 -57,862 -69,799 -75,671
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 5,691.00 5,691.00 5,691.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 04/02/22 14/02/23 09/02/24 10/02/25 10/02/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
41.47x2.11x16.43x1.87% 2.65B
21.17x4.08x14.9x3.03% 338B
18.57x2.78x12.26x3.44% 140B
24.84x3.72x15.61x2.32% 72.81B
41.98x6.76x29.35x2.2% 49.89B
35.36x2.69x14.69x1.54% 37.93B
20.33x2.84x11.82x4.37% 37.13B
23.63x1.73x11.08x2.16% 20.53B
16.25x1.55x8.9x3.26% 20.09B
39.82x5.61x27.51x1.8% 9.97B
Average 28.34x 3.39x 16.26x 2.6% 72.88B
Weighted average by Cap. 23.42x 3.72x 15.19x 2.93%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. Valuation Kobayashi Pharmaceutical Co., Ltd.